| Tel.: | 0721 / 9415-213 |
| Fax: | 0721 / 9415-214 |
| E-Mail: | contact.ka.tpmd@tentamus.com |
| www: | www.tentamedix.com |
| Inhaber: | Tentamus Group GmbH |
| Geschäftsführung: | Dr. Andreas Schenavsky |
| Laborleitung: | Dipl. Biol. Larissa Nkenmei-Pietsch, M.Sc. Linda Haeger; M.Sc. Rafal Napierala, Dipl. Biol. Christine Hünnebeck |
| Mitglied seit: |
Biological Safety / Medical Devices (ISO 10993): • Pyrogen testing: Monocyte Activation Test (Ph.Eur. 2.6.30) • Determination of Cytotoxicity in vitro (ISO 10993-5 / USP 87) • Skin testing in vitro (ISO 10993-10 / OECD TG 431 /439 / 442d/e) // Bioanalytics: • Protein characterisation by amino acid composition (ninhydrin positive substances according to Ph.Eur. 2.2.56), size and immunological reactivity // Microbiology: • Cell bank purity / Bacteriophage detection and characterisation • Bioburden / product specific recovery (ISO 11737-1) • Determination of Bacterial Endotoxins / LAL-Test (Ph.Eur. 2.6.14) • Genotoxicity / AMES Test (ISO 10993-3 / OECD TG 471) // Equipment: • Mesoscale Quickplex SQ120 • AYOXXA Lunaris protein multiplexing platform • Merck Guava Easycyte Flow Cytometer • Berthold LB 941ELISA Work Station • SYKAM High Speed Amino Acid Analyser